Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris
PaperCitations, authors & open-access status
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 139 citations, 2006 year and closed oa status.
139
Citations
2006
Year
closed
OA Status